Plenful, a trailblazer in healthcare workflow automation, proudly announces the successful closing of a $17 million funding round, which will significantly bolster its mission to streamline pharmacy and healthcare operations through the power of AI. With a focus on alleviating the burdens of manual and administrative tasks, Plenful's innovative solutions are trusted by leading pharmacy and healthcare teams, enabling them to reduce costs and drive revenue. This latest investment, backed by renowned firms such as Bessemer Venture Partners, TQ Ventures, Susa Ventures, and Waterline Ventures, among others, positions Plenful to enhance its highly configurable automation solutions. The funding will be instrumental in scaling operations, refining its product offerings—particularly in key areas like 340B auditing, savings identification, document data entry, and inventory management—and accelerating customer adoption. Founded on the premise of improving efficiency and accuracy within the healthcare sector, Plenful stands out with its commitment to high ROI use cases, making it an invaluable partner for pharmacies navigating the complexities of modern healthcare. With this funding, Plenful is poised to advance its technology, expand into new markets, and ultimately revolutionize how healthcare organizations operate. By breaking down barriers, the company aims to empower healthcare providers to focus more on patient care rather than administrative hurdles—a vision that resonates with its investors and the industry at large. Plenful is set to transform healthcare workflows for the better, and we are excited to see the continued impact of these investments.
Plenful Secures $17 Million in Series A Funding Round to Revolutionize Healthcare Operations
Recently funded · $17.0M Series aHealthcare
Get the full Plenful company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Aligned Marketplace | Series a | $20.0M | today |
| 2 |  Vals AI United States | Series a | $40.0M | today |
| 3 |
.png&w=3840&q=75)
